You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ANYTIME, ANYPLACE LEARNING FOR CRITICAL CARE

    SBC: ACADEMIC EDGE, INC.            Topic: N/A

    completion, the entire course will provide a professional certificate with continuing nursing education contact hours or can be transferred as academic credit in an undergraduate-nursing program. The model for the OCPP to be developed in this project has three components: didactic core content, clinical practicum, and a Virtual Center of Best Practices. The core ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  2. ANTI-ANDROGENIC MECHANISM OF A NEW COMPOUND

    SBC: ANDROSCIENCE CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Androgen blockage therapy may relieve the symptom of an advanced, localized prostate tumor; however, once the tumor evolves into a hormone-refractory stage, there is no effective treatment. A continuous activation of AR by antiandrogens (used in androgen blockage therapy) or other "nonconventional" agonists may contribute to prostate cancer progression in patie ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  3. SAMPLE PROCESSING CARTRIDGES FOR RAPID PCR TB DETECTION

    SBC: CEPHEID            Topic: N/A

    DESCRIPTION (provided by applicant): Conventional methods to identify and test the antibiotic susceptibility of Mycobacterium tuberculosis are both slow and insensitive. Current nucleic acid amplification-based techniques present a partial solution by offering a more rapid result, but these methods require a relatively high degree of technical sophistication. Furthermore, assay sensitivity is oft ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. ENDOVASCULAR EMBOLECTOMY FOR STROKE- EXPERIMENTAL STUDY

    SBC: CONCENTRIC-MEDICAL            Topic: N/A

    DESCRIPTION (Adapted from applicant's abstract): The application's long-term objective is to improve the treatment of acute ischemic stroke by using mechanical embolectomy for arterial recanalization. The specific aim of this project is to design and test various versions of the Clot Retriever Device (CRD), a helix shaped nitinol device made to ensnare and retrieve thrombo-emboli from cerebral art ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. NOVEL DOXORUBICIN ANALOGS:CARDIAC AND CYTOTOXIC EFFECTS

    SBC: GEM Pharmaceuticals            Topic: N/A

    Anthracyclines such as doxorubicin and daunorubicin are valuable anti- cancer drugs but their clinical utility is compromised by cumulative dose-dependent by a cumulative dose dependent cardiotoxicity. Anthracycline cardiotoxicity has been linked to free radical damage via mechanisms that involve disruption of iron regulation and formation of superoxide anion. Although the quinone moiety of anthra ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  6. P20, MOLECULAR SHORTSTOP FOR INFLAMMATORY LUNG DISEASES

    SBC: Generx+, Inc.            Topic: N/A

    The transcription factor CAAT enhancer binding protein beta (C/EBPbeta) is a key factor orchestrating the inflammatory response. Specifically, expression of the genes encoding the pro-inflammatory cytokines IL-6 and on IL-8 are regulated by C/EBPbeta. C/EBPbeta can be either an activator or an inhibitor of inflammation depending on the dominant isoforms produced. Our data indicate that airway epit ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. PRECISE 3D QCT TO MONITOR OSTEOPOROSIS THERAPY

    SBC: IMAGE ANALYSIS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant):The growing number of women receiving drug treatment for osteoporosis underscores the need for sensitive methods to monitor therapy. Because it permits selective assessment of the trabecular and cortical bone, which may respond differently to disease and therapy, quantitative computed tomography (QCT) is well-suited to this purpose. However, the ability of QCT t ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  8. ANIMAL TESTING OF A BLOCKING ANTIBODY OF PCRV

    SBC: INTERMUNE PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This grant will determine the efficacy of a humanized monoclonal antibody in treating a lethal Pseudomonas-induced lung injury. We have shown that the airspace instillation of a strain of Pseudomonas aeruginosa that contains the type Il system predictably causes lung necrosis, sepsis and death (J Clin Invest 1999). We have also shown th ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. VARIATION SCANNING WITH MISMATCH REPAIR DETECTION MRD)

    SBC: PARALLELE BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): One widely considered approach to identify susceptibility alleles is through linkage disequilibrium (LD) between these alleles and a universal set of relatively frequent SNPs distributed in all or most ethnic populations. This approach, however, may be unrealistic when variant alleles responsible for disease susceptibility are infrequent or are specific to a pa ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. HIGH THROUGHPUT GENOTYPING TECHNOLOGY

    SBC: PARALLELE BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): There is a need for inexpensive high throughput platforms for analyzing large number of single nucleotide polymorphisms. In this proposal, we describe the development of a technique, which will enable more than 10,000 SNPs to be analyzed in a single tube and its transfer to a commercial entity (ParAllele Genomcis Inc.). T ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government